Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT06945419

1 development in the corpus

NCT06945419

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 19, 2026 · PHASE 1 TRIAL

A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes

ClinicalTrials.gov

Phase 1 safety and tolerability study with completed enrollment but no results reported; early-stage characterization of a novel agent with no efficacy data.

PreliminaryEli Lilly and Company Obesity Overweight

Reported

Planned enrollment219

Study phasePhase 1

Primary outcome measureNumber of Participants with One or More Ser…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support